High prevalence of community-acquired norovirus gastroenteritis among hospitalized children: a prospective study

V Gonzalez-Galan1, A Sánchez-Fauqier, I Obando

  • 1Department of Microbiology, Hospital Virgen Del Rocio, Seville, Spain. verogonzalezgalan@hotmail.com

Insights

Norovirus was the leading cause of acute gastroenteritis in hospitalized children under five in Seville, Spain. Rotavirus infection, however, was linked to more severe clinical outcomes and lactose intolerance.

Area of Science:

  • Pediatric Infectious Diseases
  • Gastroenterology
  • Public Health Surveillance

Background:

  • Acute gastroenteritis (AGE) significantly impacts young children, often necessitating hospitalization.
  • Effective surveillance of AGE pathogens guides preventive strategies, including vaccination programs.
  • Understanding pathogen prevalence is crucial for managing pediatric morbidity.

Purpose of the Study:

  • To identify the primary viral and bacterial pathogens causing AGE in hospitalized children under five.
  • To analyze the clinical characteristics and outcomes associated with different pathogens.
  • To evaluate the incidence of mixed infections and complications like lactose intolerance.

Main Methods:

  • Prospective study of children under five admitted with AGE from April 2006 to April 2007.
  • Collection of demographic and clinical data, with post-discharge follow-up.
  • Stool sample analysis using molecular techniques (RT-PCR) for viruses and culture for bacteria.

Main Results:

  • Norovirus was the most frequent pathogen (27%), followed by rotavirus (21%).
  • Mixed infections, often with Salmonella, occurred in nearly 20% of norovirus cases.
  • Rotavirus infection correlated with higher severity scores and was linked to lactose intolerance (7.5%).

Conclusions:

  • Norovirus is the predominant cause of AGE in hospitalized young children in Seville.
  • Molecular diagnostic techniques are essential for routine surveillance of norovirus AGE.
  • Further research into pathogen-specific clinical impacts and complications is warranted.

Related Concept Videos

Bacterial Gastroenteritis01:18

Bacterial Gastroenteritis

Bacterial gastroenteritis, characterized by diarrhea, abdominal cramps, and vomiting, is often caused by ingestion of contaminated food or water and is frequently associated with pathogenic Escherichia coli strains. These microbes exploit two principal mechanisms to inflict disease.Shiga toxin–producing E. coli, also referred to as STEC—notably O157:H7—release Shiga toxins that target ribosomes, blocking protein synthesis. The B subunit of the toxin binds the host glycolipid receptor...
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care01:30

Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care

A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...